Important considerations when choosing pharmacotherapy for Graves' disease in children

Expert Opin Pharmacother. 2019 Oct;20(14):1675-1677. doi: 10.1080/14656566.2019.1638365. Epub 2019 Jul 5.

Authors

Aleksandra Król¹, Jolanta Krajewska¹, Barbara Jarzab¹

Affiliation

¹ Nuclear Medicine and Endocrine Oncology Department, Maria Sklodowska-Curie Institute - Oncology Center , Gliwice , Poland.

PMID: 31274019
DOI: 10.1080/14656566.2019.1638365

No abstract available

Keywords: Graves’ disease (GD); antithyroid drugs (ATD); long-term ATD therapy.

Publication types

Editorial